Benign mimickers of prostatic adenocarcinoma

Modern Pathology

Volumn 17, Issue 3, 2004, Pages 328-348

  Srigley, John R ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

Adenocarcinoma; Benign; Mimickers; Prostate gland

Indexed keywords

ADENOMA; ATROPHY; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; DIFFERENTIAL DIAGNOSIS; GLEASON SCORE; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MALACOPLAKIA; METAPLASIA; NEEDLE BIOPSY; NODULAR HYPERPLASIA; PARAGANGLION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATITIS; REVIEW; SEMINAL VESICLE; STROMA CELL; XANTHOMA; ADENOCARCINOMA; MALE; PATHOLOGY; PROSTATE; PROSTATE DISEASE; PROSTATE TUMOR;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PROSTATE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS;

EID: 7444261904     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800055     Document Type: Review

References (118)

1. Troxel DB, Sabella JD. Problem areas in pathology practice. Uncovered by a review of malpractice claims. Am J Surg Pathol 1994;18:821-831.
2. Troxel DB. Diagnostic pitfalls in surgical pathology-discovered by a review of malpractice claims. Int J Surg Pathol 2001;9:133-136.
3. Fody EP, West Tan M. Steering clear of malpractice claims. CAP Today, November 2002;6:38-42.
4. Jones EC, Young RH. The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland. Am J Clin Pathol 1994;101:48-64.
5. Bostwick DG, Dundore PA. Biopsy Pathology of the Prostate. Chapman and Hall: New York, 1997.
6. Gaudin PB, Reuter VE. Benign mimics of prostatic adenocarcinoma on needle biopsy. Anat Pathol 1997;2:111-134.
7. Helpap B. Differential diagnosis of glandular proliferations in the prostate. A conventional and immunohistochemical approach. Virchows Archiv 1998;433:397-405.
8. Srigley JR, Bullock M, Amin M. Small glandular patterns in the prostate gland: the differential diagnosis of small acinar carcinoma. In: Foster CS, Bostwick DG (eds). Pathology of the Prostate, Major Problems in Pathology Series, Vol. 34. WB Saunders Company: Philadelphia, 1998, pp. 126-156.
9. Young RH, Srigley JR, Amin MB, et al. Tumors of the prostate gland, seminal vesicles, male urethra and penis. Atlas of Tumor Pathology, 3rd Series, Fascicle 28, AFIP, 2000.
10. Epstein JI, Yang XJ. Prostate Biopsy Interpretation. Lippincott, Williams & Wilkins: Philadelphia, 2002.
11. Gleason DF. Classification of prostatic carcinoma. Cancer Chemother Rep 1996;50:125-128.
12. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed). Urologic Pathology: The Prostate. Lea & Febiger: Philadelphia, 1977, pp. 171-197.
13. Kuo TT, Gomez LG. Monstrous epithelial cells in human epididymis and seminal vesicles. A pseudomalignant change. Am J Surg Pathol 1981;5:483-490.
14. Jensen KM, Sonneland P, Madsen PO. Seminal vesicle tissue in 'resectate' of transurethral resection of prostate. Urology 1983;22:20-23.
15. Srigley JR. Small acinar patterns in the prostate gland with emphasis on atypical adenomatous hyperplasia and small acinar carcinoma. Semin Diagn Pathol 1988;5:254-272.
16. Arias-Stella J, Takano-Moron J. Atypical epithelial changes in the seminal vesicle. Arch Pathol 1958;66:761-766.
17. Brennick JB, O'Connell JX, Dickersin GR, et al. Lipofuscin pigmentation (so-called 'melanosis') of the prostate. Am J Surg Pathol 1994;18:446-454.
18. Leung CS, Srigley JR. Distribution of lipochrome pigment in the prostate gland: biological and diagnostic implications. Hum Pathol 1995;26:1302-1307.
19. Amin MB, Bostwick DG. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. Mod Pathol 1996;9:791-795.
20. Cina SJ, Silberman MA, Kahane H, et al. Diagnosis of Cowper's glands on prostate needle biopsy. Am J Surg Pathol 1997;21:550-555.
21. Saboorian MH, Huffman H, Ashfaq R, et al. Distinguishing Cowper's glands from neoplastic and pseudoneoplastic lesions of prostate. Immunohistochemical and ultrastructural studies. Am J Surg Pathol 1997;21:1069-1074.
22. Grignon DJ, O'Malley FP. Mucinous metaplasia in the prostate gland. Am J Surg Pathol 1993;17:287-290.
23. Gardner. Jr WA, Culberson DE. Atrophy and proliferation in the young adult prostate. J Urol 1987;137:53-56.
24. Billis A. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 1998;11:47-54.
25. Bostwick DG, Egbert BM, Fajardo LF. Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 1982;6:541-551.
26. Sheaff MT, Baithun SI. Effects of radiation on the normal prostate gland. Histopathology 1997;30:341-348.
27. Cheng L, Cheville JC, Bostwick DG. Diagnosis of prostate cancer in needle biopsies after radiation therapy. Am J Surg Pathol 1999;23:1173-1183.
28. Têtu B, Srigley JR, Boivin J, et al. Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. Am J Surg Pathol 1991;15:115-120.
29. Civantos F, Marcial MA, Banks ER, et al. Pathology of androgen deprivation in prostatic carcinoma. A comparative study of 173 patients. Cancer 1995;75:1634-1641.
30. Bullock MJ, Srigley JR, Klotz LH, et al. Pathological effects of neoadjuvant cyproterone acetate on non-neoplastic prostate, prostatic intraepithelial neoplasia and adenocarcinoma: a detailed analysis of radical prostatectomy specimens from a randomized trial. Am J Surg Pathol 2002;26:1400-1413.
31. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol. 1989;13:389-396.
32. Epstein JI, Walsh PC, Sanfilippo F. Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol 1996;20:851-857.
33. Cina SJ, Epstein JI. Adenocarcinoma of the prostate with atrophicfeatures. Am J Surg Pathol 1997;21:289-295.
34. Kaleem Z, Swanson P, Vollmer RT, et al. Prostatic adenocarcinoma with atrophic features: a study of 202 consecutive completely embedded radical prostatectomy specimens. Am J Clin Pathol 1998;109:695-703.
35. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bact 1954;68:617-621.
36. Cheville JC, Bostwick DG. Post-atrophic hyperplasia of the prostate. A histologicmimic of prostatic adenocarcinoma. Am J Surg Pathol 1995;19:1068-1076.
37. Oppenheimer JR, Wills ML, Epstein JI. Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol 1998;22:440-445.
38. Amin MB, Tamboli P, Varma M, et al. Post-atrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. Am J Surg Pathol 1999;8:925-931.
39. Liavag I. Atrophy and regeneration in the pathogenesis of prostatic carcinoma. Acta Pathol Microbiol Scand 1968;73:338-350.
40. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate. Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-1992.
41. Putzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urol 2000;56:828-832.
42. Nelson WG, De Marzo AM, Deweese TL. The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urol 2001;57:39-45.
43. Epstein J. Inflammatory atypia vs prostate adenocarcinoma with inflammation. In: Epstein J (ed). Differential Diagnosis in Pathology, UrologicDiseases. Igaku-Shoin: New York, 1992, pp 82-83.
44. Bennett BD, Richardson PH, Gardner WA. Histopathology and cytology of prostatitis. In: Lepor H, Lawson R (eds). Prostate Diseases. WB Saunders: Philadelphia, 1993, pp 399-413.
45. Chan TY, Epstein JI. Follow up of atypical prostate needle biopsies suspicious for cancer. Urology 1999;53:351-355.
46. Young RH. Nephrogenic adenomas of the urethra involving the prostate gland: a report of two cases of a lesion that may be confused with prostatic adenocarcinoma. Mod Pathol 1992;5:617-620.
47. Daroca PJ, Martin AA, Reed RJ, et al. Nephrogenic adenoma of the prostatic urethra. A report of these cases including a case with infiltration of the prostatic stroma. J Urol Pathol 1993;1:157-172.
48. Malpica A, Ro JY, Troncoso P, et al. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol 1994;25:390-395.
49. Allan CH, Epstein JI. Nephrogenic adenoma of the prostatic urethra: a mimicker of prostate adenocarcinoma. Am J Surg Pathol 2001;25:802-808.
50. Mazal PR, Schaufler R, Altenhuber-Müller R, et al. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients. N Engl J Med 2002;347:653-659.
51. Cleary KR, Choi HY, Ayala AG. Basal cell hyperplasia of the prostate of the prostate. Am J Clin Pathol 1983;80:850-854.
52. Grignon DJ, Ro JY, Ordonez NG, et al. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol 1988;19:1425-1433.
53. Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 1993;17:645-659.
54. Van de Voorde W, Baldewijns M, Lauweryns J. Florid basal cell hyperplasia of the prostate. Histopathology 1994;24:341-348.
55. Thorson P, Swanson PE, Vollmer RT, Humphrey PA. Basal cell hyperplasia in the peripheral zone of the prostate. Mod Pathol 2003;16:598-606.
56. Epstein JI, Armas OA. Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 1992;16:1205-1214.
57. Humphrey PA, Kaleem Z, Swanson P, et al. Pseudohyperplastic prostatic adenocarcinoma. Am J Surg Pathol 1998;22:1239-1246.
58. Levi AW, Epstein JI. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol 2000;24:1039-1046.
59. Young RH, Clement PB. Sclerosing adenosis of the prostate. Arch Pathol Lab Med 1987;111:363-366.
60. Chen KT, Schiff JJ. Adenomatoid prostatic tumor. Urology 1983;21:88-89.
61. Jones EC, Clement PB, Young RH. Sclerosing adenosis of the prostate gland. A clinicopathological and immunohistochemical study. Am J Surg Pathol 1991;15:1171-1180.
62. Sakamoto N, Tsuneyoshi M, Enjoji M. Sclerosing adenosis of the prostate. Histopathologic and immunohistochemical analysis. Am J Surg Pathol 1991;15:660-667.
63. Grignon DJ, Ro JY, Srigley JR, et al. Sclerosing adenosis of the prostate gland. A lesion showing myoepithelial differentiation. Am J Surg Pathol 1992;16:383-391.
64. Gagucas RJ, Brown RW, Wheeler TM. Verumontanum mucosal gland hyperplasia. Am J Surg Pathol 1995;19:30-36.
65. Gaudin PB, Wheeler TM, Epstein JI. Verumontanum mucosal gland hyperplasia (VMGH) in prostatic needle biopsy specimens: a mimic of low-grade prostatic adenocarcinoma. Am J Clin Pathol 1995;104:620-626.
66. Muezzinogou B, Erdamar S, Chakraborty S, et al. Verumontanum mucosal gland hyperplasia is associated with atypical adenomatous hyperplasia of the prostate. Arch Pathol Lab Med 2001;125:358-360.
67. Gikas PW, Del Buono EA, Epstein JI. Florid hyperplasia of mesonephric remnants involving prostate and periprostatic tissue. Possible confusion with adenocarcinoma. Am J Surg Pathol 1993;17:454-460.
68. Amin MB. Florid hyperplasia of mesonephric remnants: yet another differential diagnostic consideration under 'small acinar proliferations of the prostate'. Adv Anat Pathol 1995;2:108-113.
69. Val-Bernal JF, Gomez-Ortega JM. Hyperplasia of prostatic mesonephric remnants: a potential pitfall in the evaluation of prostate gland biopsy. J Urol 1995;154:1138-1139.
70. Muir TE, Pacelli A, Farrow GM, et al. Mesonephric remnants of the prostate: incidence and clinical significance [Abstract]. Mod Pathol 1997;10:83A.
71. Jimenez RE, Raval MF, Spanta R, et al. Mesonephric remnants hyperplasia. Pitfall in the diagnosis of prostatic adenocarcinoma. J Urol Pathol 1998;9:83-92.
72. McNeal JE. Morphogenesis of prostatic carcinoma. Cancer 1965;18:1659-1666.
73. Gleason DF. Atypical hyperplasia, benign hyperplasia, and well-differentiated adenocarcinoma of the prostate. Am J Surg Pathol 1985;9(Suppl):a53-a67.
74. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24:819-832.
75. Amin MB, Ro JY, Ayala AG. Putative precursor lesions of prostatic adenocarcinoma: fact or fiction? Mod Pathol 1993;6:476-483.
76. Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 1995;19:506-518.
77. Grignon DJ, Sakr WA. Atypical adenomatous hyperplasia of the prostate: a critical review. Eur Urol 1996;30:2206-2211.
78. Cheng L, Shan A, Cheville JC, et al. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res 1998;58:389-391.
79. Bostwick DG, Algaba F, Amin MB, et al. Consensus statement on terminology: recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate [Letter]. Am J Surg Pathol 1994;18:1069-1070.
80. Epstein JI. Adenosis vs. atypical adenomatous hyperplasia of the prostate [Letter]. Am J Surg Pathol 1994;18:1070-1071.
81. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in transurethral resections specimens. Am J Surg Pathol 1994;18:863-870.
82. Gaudin PB, Epstein JI. Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol 1995;19:737-747.
83. Epstein JI. Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma. Path Res Pract 1995;191:888-898.
84. Brawn PN. Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma. Cancer 1982;49:826-833.
85. O'Malley FP, Grignon DJ, Shum DT. Usefulness of immunoperoxidase staining with high-molecular weight cytokeratin in the differential diagnosis of small acinar lesions of the prostate gland. Virchows Arch [A] 1990;417:191-196.
86. Helpap B. The biological significance of atypical hyperplasia of the prostate. Virchows Arch [A] 1980;387:307-317.
87. Helpap B. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathol Res Pract 1995;191:904-907.
88. Ghazizadah M, Sasaki Y, Oguro T, et al. Silver staining of nucleolar organizer regions in prostate lesions. Histopathology 1991;19:369-372.
89. Doll JA, Zhu X, Furman J, et al. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 1999;155:967-971.
90. Yang XJ, Wu CL, Woda BA, et al. Expression of α-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 2002;26:921-925.
91. Epstein JI, Fynheer J. Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma? Hum Pathol 1992;23:1321-1325.
92. Goldstein NS, Qian J, Bostwick DG. Mucin expression in atypical adenomatous hyperplasia of the prostate. Hum Pathol 1995;26:887-891.
93. Ayala AG, Srigley JR, Ro JY, et al. Clear cell cribriform hyperplasia of prostate. Report of 10 cases. Am J Surg Pathol 1986;10:665-671.
94. Frauenhoffer EE, Ro JY, El-Naggar AK, et al. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. Am J Clin Pathol 1991;95:446-453.
95. Reed RJ. Consultation case: prostate (prostatectomy)-adenoid basal cell tumor-multifocal basal cell hyperplasia. Am J Surg Pathol 1984;8:699-704.
96. Young RH, Frierson HF, Mills SE, et al. Adenoid c0ystic-like tumor of the prostate gland. A report of two cases and review of the literature on 'adenoid cystic carcinoma' of the prostate. Am J Clin Pathol 1988;89:49-56.
97. Freedman SR, Goldman RL. Normal paraganglia in the human prostate. J Urol 1975;113:874-875.
98. Rode J, Bentley A, Parkinson C. Paraganglial cells of urinary bladder and prostate: potential diagnostic problem. J Clin Pathol 1990;43:13-16.
99. Ostrowski ML, Wheeler TM. Paraganglia of the prostate. Location, frequency, and differentiation from prostatic adenocarcinoma. Am J Surg Pathol 1994;18:412-420.
100. Sebo TJ, Bostwick DG, Farrow GM, et al. Prostatic xanthoma: a mimic of prostate adenocarcinoma. Hum Pathol 1994;25:386-389.
101. Bostwick DG, Chang L. Overdiagnosis of prostatic adenocarcinoma. Sem Urol Oncol 1999;17:199-205.
102. McClure J. Malakoplakia of the prostate: a report of two cases and a review of the literature. J Clin Pathol 1979;32:629-632.
103. Koga S, Arakaki Y, Matsuoka M, et al. Malakoplakia of prostate. Urology 1986;27:160-161.
104. Thrasher JB, Sutherland RS, Limoge JP, et al. Transrectal ultrasound and biopsy in diagnosis of malakoplakia of prostate. Urology 1992;39:262-265.
105. Liu S, Christmas TJ, Kirby RS. Malakoplakia and carcinoma of the prostate. Br J Urol 1993;72:120-121.
106. Sarma HN, Ramesh K, al Fituri O, et al. Malakoplakia of the prostate gland-report of two cases and review of the literature. Scand J Urol Nephrol 1996;30:155-157.
107. Lopez-Plaza I, Bostwick DG. Prostatitis. In: Bostwick DG (ed). Pathology of Prostate. Churchill Livingstone: New York, 1990, pp. 15-30.
108. Bennett BD, Richardson PH, Gardner WA. Histopathology and cytology of prostatitis. In: Lepor H, Lawson R (eds). Prostate Diseases. WB Saunders: Philadelphia, 1993, pp. 399-413.
109. Helpap B. Histological and immunohistochemical study of chronic prostatic inflammation with and without benign prostatic hyperplasia. J Urol Pathol 1994;2:49-64.
110. Kelalis PP, Greene LF, Harrison EG. Granulomatous prostatitis. A mimic of carcinoma of the prostate. JAMA 1965;191:287-289.
111. Taylor EW, Wheelis RF, Correa RJ, et al. Granulomatous prostatitis: confusion clinically with carcinoma of the prostate. J Urol 1977;117:3168.
112. Presti B, Weidner N. Granulomatous prostatitis and poorly differentiated prostate carcinoma. Their distinction with the use of immunohistochemical methods. Am J Clin Pathol 1991;95:330-334.
113. Oppenheimer JR, Kahane H, Epstein JI. Granulomatous prostatitis on needle biopsy. Arch Pathol Lab Med 1997;121:724-729.
114. Alguacil-Garcia A. Artifactual changes mimicking signet ring cell carcinoma in transurethral prostatectomy specimens. Am J Surg Pathol 1986;10:795-800.
115. Schned AR. Artifactual signet ring cells. Am J Surg Pathol 1987;11:736-737.
116. Wang HL, Humphrey PA. Exaggerated signet-ring cell change in stromal nodule of prostate. A pseudoneoplastic proliferation. Am J Surg Pathol 2002;26:1066-1070.
117. Jiang Z, Woda BA, Rock KL, et al. P504S. A new molecular marker for the detection of prostate cancer. Am J Surg Pathol 2001;25:1397-1404.
118. Jiang Z, Wu CL, Woda BA, et al. P504S/α-methyl-acyl-CoA racemase. A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 2002;26:1169-1174.